prostate cancer Myovant Sciences
Myovant Sciences completes enrolment for Phase III HERO trial
Myovant Sciences has completed patient enrolment for its Phase III HERO clinical trial assessing the safety and efficacy of relugolix…
Myovant Sciences has completed patient enrolment for its Phase III HERO clinical trial assessing the safety and efficacy of relugolix…